The impact of N-acetylcysteine and ascorbic acid in contrast-induced nephropathy in critical care patients: an open-label randomized controlled study

BACKGROUND: The aim was to investigate whether the use of N-acetylcysteine and ascorbic acid reduce contrast-induced nephropathy incidence in critical care patients. METHODS: This was a one-center, two-arm, prospective, randomized, open-label, controlled trial in the Intensive Care Unit of the Unive...

Descripción completa

Detalles Bibliográficos
Autores principales: Palli, Eleni, Makris, Demosthenes, Papanikolaou, John, Garoufalis, Grigorios, Tsilioni, Irini, Zygoulis, Paris, Zakynthinos, Epaminondas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664844/
https://www.ncbi.nlm.nih.gov/pubmed/29089038
http://dx.doi.org/10.1186/s13054-017-1862-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664844/
https://www.ncbi.nlm.nih.gov/pubmed/29089038
http://dx.doi.org/10.1186/s13054-017-1862-3

Ejemplares similares